Old Web
English
Sign In
Acemap
>
authorDetail
>
Joanne Wing Yan Chiu
Joanne Wing Yan Chiu
Queen Mary University of London
Medicine
Internal medicine
Oncology
Hepatocellular carcinoma
immune checkpoint inhibitors
4
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Nivolumab/pembrolizumab in Child-Pugh grade B/C patients with advanced HCC.
2021
Journal of Clinical Oncology
Jeffrey Sum Lung Wong
Gin Wai Kwok
Vikki Tang
Bryan Li
Roland Leung
Joanne Wing Yan Chiu
Ka Wing Ma
W.H. She
Wing Yan Josephine Tsang
Tan To Cheung
Thomas Yau
Show All
Source
Cite
Save
Citations (1)
Efficacy and safety analysis of Chinese patients in monarchE: Abemaciclib combined with adjuvant endocrine therapy for high risk HR+, HER2- early breast cancer.
2021
Journal of Clinical Oncology
Shao Zhi-min
Qingyuan Zhang
Chuan Gui Song
Quchang Ouyang
Zhenzhen Liu
Qiang Liu
Jifeng Feng
Joanne Wing Yan Chiu
Ling-Ming Tseng
Chenxi Qian
Show All
Source
Cite
Save
Citations (0)
Cabozantinib in advanced HCC patients previously treated with immune checkpoint inhibitors: A territory-wide cohort study.
2021
Journal of Clinical Oncology
Jeffrey Sum Lung Wong
Yawen Dong
Vikki Tang
Thomas W.T. Leung
Cynthia S. Y. Yeung
Anna Tai
Ada Law
Tracy Cy Shum
Gin Wai Kwok
Bryan Li
Roland Leung
Joanne Wing Yan Chiu
Ka Wing Ma
W.H. She
Wing Yan Josephine Tsang
Tan To Cheung
Thomas Yau
Show All
Source
Cite
Save
Citations (0)
Outcomes of tyrosine kinase inhibitors after immunotherapy in advanced hepatocellular carcinoma: A multi-center study.
2021
Journal of Clinical Oncology
Thomas Yau
Joycelyn Jie Xin Lee
Jeffrey Sum Lung Wong
Vikki Tang
Jess L.C. Chan
Gin Wai Kwok
Joanne Wing Yan Chiu
Roland Leung
Bryan Li
Wing Yan Josephine Tsang
Tan To Cheung
Su Pin Choo
Wai Meng David Tai
Show All
Source
Cite
Save
Citations (0)
1